2010, FDA, Food and Drug Administration and Training

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2010

FDA

Food and Drug Administration

Training

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

European Pharmaceutical Review

JULY 17, 2023

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 million per approved drug. billion (3.3

Food and Drug Administration

Food and Drug Administration Training Pharmaceutical Food

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

AUGUST 23, 2022

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

FDA

FDA Food and Drug Administration Pharma Pharmaceutical manufacturing

Pharma Rep Focus

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

Common pharma compliance concerns cited by FDA warning letters

Stay Connected